National burden and risk factors of diabetes mellitus in China from 1990 to 2021: Results from the Global Burden of Disease study 2021

被引:5
|
作者
Deng, Wenzhen [1 ,2 ]
Zhao, Li [1 ,2 ]
Chen, Cheng [2 ]
Ren, Ziyu [1 ]
Jing, Yuanyuan [1 ]
Qiu, Jingwen [1 ]
Liu, Dongfang [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, 74 Linjiang Rd, Chongqing 400010, Peoples R China
[2] Qianjiang Cent Hosp Chongqing, Dept Endocrinol, Qianjiang, Peoples R China
关键词
diabetes mellitus; disability-adjusted life years; global disease burden; incidence; prevalence; INSULIN-RESISTANCE; INTENSITY EXERCISE; BODY-MASS; TYPE-2; EPIDEMIOLOGY; PREVENTION; PREVALENCE; OBESITY; METAANALYSIS; MORTALITY;
D O I
10.1111/1753-0407.70012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundIn recent years, the prevalence and mortality rates of diabetes have been rising continuously, posing a significant threat to public health and placing a heavy burden on the population. This study was conducted to describe and analyze the burden of diabetes in China from 1990 to 2021 and its attributable risk factors.MethodsUtilizing data from the Global Burden of Disease Study 2021, we analyzed the incidence, prevalence, and disability-adjusted life years (DALYs) of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) in China from 1990 to 2021. We extracted sex- and age-specific data on diabetes, focusing on DALYs, years lived with disability, and years of life lost. Bayesian meta-regression and spatiotemporal Gaussian process regression were used to estimate disease parameters. Age-standardized rates (ASRs) and estimated annual percentage changes (EAPC) were calculated using direct standardization and log-linear regression. The population-attributable fractions were also determined for each risk factor.ResultsIn 2021, the absolute number of incident diabetes mellitus (DM) cases was estimated at 4003543.82, including 32 000 T1DM and 3971486.24 T2DM cases. The ASRs were 244.57 for DM, 2.67 for T1DM, and 241.9 for T2DM (per 100 000 population). The absolute number of prevalent DM cases was 117288553.93, including 1442775.09 T1DM and 115845778.84 T2DM cases. The ASRs were 6142.29 for DM, 86.78 for T1DM, and 6055.51 for T2DM (per 100 000 population). In 2021, there were 178475.73 deaths caused by DM, with an ASR of mortality of 8.98 per 100 000 population. The DALYs due to DM in 2021 were 11713613.86, with an ASR of 585.43 per 100 000 population and an EAPC of 0.57. This increase can be attributed to several factors, including high body mass index, air pollution, and dietary habits.ConclusionsThe burden of diabetes is considerable, with high prevalence and incidence rates, highlighting the urgent need for public health interventions. Addressing factors like high fasting plasma glucose, body mass index, air pollution, and dietary risks through effective interventions is critical. imageConclusionsThe burden of diabetes is considerable, with high prevalence and incidence rates, highlighting the urgent need for public health interventions. Addressing factors like high fasting plasma glucose, body mass index, air pollution, and dietary risks through effective interventions is critical. image HighlightsThe incidence, prevalence, and DALYs rate of diabetes in China are at relatively high levels, with a severe and rapidly growing burden of disability, particularly prominent among males. Interventions should be strengthened for major factors contributing to the diabetes burden, including high fasting plasma glucose, high body mass index, air pollution, and dietary risks. image
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Burden of alopecia areata in China, 1990-2021: Global Burden of Disease Study 2021
    Li Xiangqian
    Liu Huixin
    Ren Wenhui
    Zhu Qijiong
    Yin Peng
    Wang Lijun
    Zhang Jianzhong
    Qi Jinlei
    Zhou Cheng
    中华医学杂志英文版, 2025, 138 (03)
  • [42] Burden of alopecia areata in China, 1990-2021: Global Burden of Disease Study 2021
    Li, Xiangqian
    Liu, Huixin
    Ren, Wenhui
    Zhu, Qijiong
    Yin, Peng
    Wang, Lijun
    Zhang, Jianzhong
    Qi, Jinlei
    Zhou, Cheng
    CHINESE MEDICAL JOURNAL, 2025, 138 (03) : 318 - 324
  • [43] Burden of non-communicable diseases in China and its provinces, 1990-2021: Results from the Global Burden of Disease Study 2021
    Liu, Hanxiao
    Yin, Peng
    Qi, Jinlei
    Zhou, Maigeng
    CHINESE MEDICAL JOURNAL, 2024, 137 (19) : 2325 - 2333
  • [44] Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021
    Li, Xin-yu
    Kong, Xiang-meng
    Yang, Cheng-hao
    Cheng, Zhi-feng
    Lv, Jia-jie
    Guo, Hong
    Liu, Xiao-hong
    ECLINICALMEDICINE, 2024, 75
  • [45] Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
    Han, Hannah
    Letourneau, Ian D.
    Abate, Yohannes Habtegiorgis
    Abdelmasseh, Michael
    Abu-Gharbieh, Eman
    Adane, Tigist Demssew
    Ahinkorah, Bright Opoku
    Ahmad, Aqeel
    Ahmadi, Ali
    Ahmed, Ayman
    Alhalaiqa, Fadwa Naji
    Al-Sabah, Salman Khalifah
    Al-Worafi, Yaser Mohammed
    Amu, Hubert
    Andrei, Catalina Liliana
    Anoushiravani, Amir
    Arabloo, Jalal
    Aravkin, Aleksandr Y.
    Ashraf, Tahira
    Azadnajafabad, Sina
    Baghcheghi, Nayereh
    Bagherieh, Sara
    Bantie, Berihun Bantie
    Bardhan, Mainak
    Basile, Guido
    Bayleyegn, Nebiyou Simegnew
    Behnoush, Amir Hossein
    Bekele, Alehegn
    Bhojaraja, Vijayalakshmi S.
    Bijani, Ali
    Biondi, Antonio
    Burkart, Katrin
    Dinh-Toi Chu
    Chukwu, Isaac Sunday
    Cruz-Martins, Natalia
    Dai, Xiaochen
    Demessa, Berecha Hundessa
    Dhali, Arkadeep
    Diaz, Daniel
    Thanh Chi Do
    Dodangeh, Milad
    Dongarwar, Deepa
    Dsouza, Haneil Larson
    Ekholuenetale, Michael
    Ekundayo, Temitope Cyrus
    El Sayed, Iman
    Elhadi, Muhammed
    Fagbamigbe, Adeniyi Francis
    Fakhradiyev, Ildar Ravisovich
    Ferrara, Pietro
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (09): : 825 - 858
  • [46] Global disparities in the burden of pancreatic cancer (1990–2021): insights from the 2021 Global Burden of Disease study
    Wei Liu
    Li Rao
    Zhengguo Qiao
    Gang Wang
    Bin Li
    Genhai Shen
    BMC Cancer, 25 (1)
  • [47] Early-onset Parkinson's disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: Results from the global burden of disease study 2021
    Wang, Jiayue
    Cheng, Nan
    Yao, Zhen
    Liu, Jinghan
    Kan, Xiaoru
    Hui, Zhenliang
    Chen, Jun
    PARKINSONISM & RELATED DISORDERS, 2025, 134
  • [48] Global, regional, and national mortality of larynx cancer from 1990 to 2021: results from the global burden of disease study
    Han, Deqian
    Lee, Hoi Leong
    Oung, Qi Wei
    Lee, Chia Hau
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
  • [49] Burden and survival of colorectal cancer in china from 1990 to 2021: findings from the global burden of disease study
    Mai, Boyuan
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55
  • [50] Global, regional, and national burden of pancreatic cancer from 1990 to 2021, its attributable risk factors, and projections to 2050: a systematic analysis of the global burden of disease study 2021
    Li, Tianyu
    Lin, Chen
    Wang, Weibin
    BMC CANCER, 2025, 25 (01)